Coloplast A/S - Q1 2025/26 Earnings Release - Invitation for conference call on 6 Feb 2026 at 11.00am CET

About this update from Coloplast A/s Class B

Friday, 6 February 2026 at 11:00-12:00am CET In connection with the publication of Coloplast’s interim financial results for Q1 2025/26, to be released same day around 07.30am CET, Coloplast will host a conference call to present the financial results and answer questions from investors and financial analysts. A presentation will be available on Coloplast’s website approximately 1 hour before the conference call. The webcast of the conference call will be available during and after the event. Coloplast will be represented by: Lars Rasmussen - Interim CEO Anders Lonning-Skovgaard  -   Executive Vice President, CFO Kristine Husted Munk - Senior Director, Investor Relations Simone Dyrby Helvind - Senior Manager, Investor Relations Webcast For participants who do not wish to actively participate in the Q&A session, please access the conference call as a webcast via the link below: Access the webcast here Dial-in details To actively participate in the Q&A session, please sign up ahead of the conference call on the link below to receive an email with dial-in details. Register for the conference call here   For more information, please contact: Kristine Husted Munk - Senior Director, Investor Relations Tel.: +45 4911 1800 / direct: +45 4911 3266. E-mail:  [email protected] Simone Dyrby Helvind - Senior Manager, Investor Relations Tel.: +45 4911 1800 / direct: +45 4911 2981. E-mail:  [email protected] Julie Sommer Müggler - Coordinator & PA, Investor Relations Tel.: +45 4911 1800 / direct: +45 4911 3161. E-mail:  [email protected]   Coloplast will be available on individual phone lines after the conference call for further questions. Attachment

View stock analysis, news, and events for Coloplast A/s Class B